South Korean Pharmaceuticals & Biotech Mid-Large Cap Stocks

PharmaResearch

Market Cap: ₩3.1t

Operates as a biopharmaceutical company primarily in South Korea.

Yuhan

Market Cap: ₩5.7t

Operates as a pharmaceutical company in South Korea and internationally.

Samsung BiologicsLtd

Market Cap: ₩63.6t

Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.

D&D Pharmatech

Market Cap: ₩4.9t

Engages in the research and development and manufacturing of pharmaceuticals in South Korea.

Samsung Epis Holdings

Market Cap: ₩10.7t

A biotechnology company, manage the portfolio of biopharmaceutical products.

SK bioscienceLtd

Market Cap: ₩3.0t

Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.

L&C BIOLTD

Market Cap: ₩2.3t

Operates as a research and development company in tissue regeneration medicine.

Hanall Biopharma

Market Cap: ₩2.6t

A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.

NatureCellLtd

Market Cap: ₩1.9t

Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.

Hanmi Pharm

Market Cap: ₩5.2t

A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.

Peptron

Market Cap: ₩4.8t

Engages in the development of peptide-based medicines.

SK Biopharmaceuticals

Market Cap: ₩6.8t

A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.

Mezzion PharmaLtd

Market Cap: ₩1.9t

Develops, manufactures, and sells pharmaceutical products in South Korea.

ABL Bio

Market Cap: ₩5.5t

A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.

Hugel

Market Cap: ₩2.6t

Develops and manufactures biopharmaceuticals in South Korea and internationally.

Celltrion Pharm

Market Cap: ₩1.9t

A pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.

ALTEOGEN

Market Cap: ₩18.9t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Aimed Bio

Market Cap: ₩1.7t

Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.

Caregen

Market Cap: ₩3.5t

A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.

Sam Chun Dang Pharm

Market Cap: ₩5.9t

Engages in the manufacturing and sale of pharmaceutical products in South Korea.

Kolon TissueGene

Market Cap: ₩8.7t

Develops cell therapies for orthopedic diseases and other unmet medical needs.

ST PharmLtd

Market Cap: ₩2.5t

Provides manufacturing services for active pharmaceutical ingredient and intermediate.

Celltrion

Market Cap: ₩37.4t

A biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products.

OliX Pharmaceuticals

Market Cap: ₩2.7t

A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.

LigaChem Biosciences

Market Cap: ₩5.0t

A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.

Voronoi

Market Cap: ₩3.5t

Researches, develops, and discovers small molecule kinase inhibitors in South Korea.